Magic mushroom compound psilocybin found safe for consumption in largest ever controlled study
link
summary
This article discusses recent research on the potential use of psilocybin, the active compound in magic mushrooms, for the treatment of depression. The article highlights a study conducted by researchers at King's College London which found that psilocybin therapy had a significant impact on reducing symptoms of depression in participants who had not responded to traditional treatments. The study involved a small sample size, but the results showed promise and have sparked further interest in psychedelic-based treatments for mental health conditions. The article also explores the history of psychedelic research and the current regulatory challenges in studying these substances. Overall, the article presents the potential of psilocybin therapy as a novel approach to addressing depression.